Page last updated: 2024-10-21

1,3-dipropyl-8-cyclopentylxanthine and Conus Medullaris Syndrome

1,3-dipropyl-8-cyclopentylxanthine has been researched along with Conus Medullaris Syndrome in 1 studies

DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.

Research Excerpts

ExcerptRelevanceReference
"To evaluate the effect of adenosine on thermal hyperalgesia after spinal cord injury (SCI)."1.36Adenosine A1 receptor agonists reduce hyperalgesia after spinal cord injury in rats. ( Horiuchi, H; Morino, T; Ogata, T; Yamamoto, H, 2010)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Horiuchi, H1
Ogata, T1
Morino, T1
Yamamoto, H1

Other Studies

1 other study available for 1,3-dipropyl-8-cyclopentylxanthine and Conus Medullaris Syndrome

ArticleYear
Adenosine A1 receptor agonists reduce hyperalgesia after spinal cord injury in rats.
    Spinal cord, 2010, Volume: 48, Issue:9

    Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor

2010